Jair Bolsonaro Robert F.Servicescience Brazil hospital covid-19 patient Jair Bolsonaro Robert F.Servicescience Brazil

‘Too good to be true’: Doubts swirl around trial that saw 77% reduction in COVID-19 mortality

Reading now: 827
www.sciencemag.org

Robert F. ServiceScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.It would be the best news by far in COVID-19 treatment: According to a preprint published on 22 June, an experimental prostate cancer drug named proxalutamide reduced deaths in hospitalized COVID-19 patients by 77% in a clinical trial in Brazil.

The preprint also claims the drug, which blocks the activity of androgens—male hormones such as testosterone—cut patients’ average hospital stay by 5 days, far more than any other treatment yet tested.

Interim results of the study, announced at a press conference in March, led President Jair Bolsonaro to tout proxalutamide as a wonder cure and spurred Brazilian doctors to dose patients with similar drugs.But.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA